BioSpace News Archive

Business

ChemoCentryx: Avacopan Conditional Marketing Authorization Application Accepted for Regulatory Review by European Medicines Agency

Under the terms of its kidney health alliance with VFMCRP, ChemoCentryx will receive a milestone payment triggered by this validation of the avacopan CMA application by the EMA.

January 4, 2018
·
13 min read
Celtaxsys Secures Private Financing to Advance Acebilustat Phase III Cystic Fibrosis (CF) Program Preparatory Activities

In conjunction with the financing, Khalil Barrage, Managing Director at Invus, will join Celtaxsys’ board of directors.

January 4, 2018
·
4 min read
Business

Paul Stead Joins Adaptimmune as Vice President of Business Development

Paul joins Adaptimmune, most recently, from Inovio Pharmaceuticals, Inc.

January 4, 2018
·
3 min read
Medigene AG: Expitope 2.0 Helps to Identify Safer Antigens for Immunotherapy of Cancer

MediGene AG announces that a scientific article has been published in the current issue of “BMC Cancer”.

January 4, 2018
·
4 min read
Drug Development

Cidara Therapeutics: Newly Published Journal of Antimicrobial Chemotherapy Supplement Provides Insights into the Future of Echinocandin Therapy for Invasive Fungal Infections

The papers reviews evidence and provides insights into the future of echinocandin therapy, including strategies for the treatment and prevention of life-threatening invasive fungal infections.

January 4, 2018
·
5 min read
Drug Development

Emergent BioSolutions Initiates Phase II Clinical Study to Evaluate FLU-IGIV to Treat Serious Influenza A Infection

This Phase 2 clinical study will enroll approximately 75 adult patients hospitalized with serious illness caused by influenza A infection in up to 50 sites within the U.S.

January 4, 2018
·
3 min read
Business

Orion to Renew Operating Model of Its Laboratories

As a result, the company will launch co-operation negotiations in the laboratory operations of pharmaceutical production, quality assurance and R&D in Espoo and Turku, and in Fermion’s laboratories in Hanko, Espoo and Oulu.

January 4, 2018
·
1 min read
Policy

Vifor Pharma’s Veltassa Approved for Marketing in Switzerland for the Treatment of Hyperkalaemia

Veltassa is a sodium-free potassium binder approved for the treatment of hyperkalaemia in adults.

January 4, 2018
·
4 min read
ASLAN Pharma to Present at J.P. Morgan Healthcare Conference

Carl Firth, Ph.D., CEO, will present an overview of the company at the 36th Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2018 at 10:30 a.m. PT.

January 4, 2018
·
1 min read
Miracor Medical Raises €25M

The new capital will be used to further develop and commercialize the PiCSO Impulse System.

January 4, 2018
·
3 min read